OPM tells FEHB insurers to cut costs, curb vaccine cash incentives and tighten GLP-1 coverage

OPM’s annual guidance to FEHB carriers urges insurers to reduce costs by ending cash incentives tied to childhood vaccine uptake and by requiring step therapy before covering GLP-1 drugs for obesity. The direction could shape FEHB plan design and prior-authorization rules in the next plan year.